Yang Ding
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 29
- Cancer Research top 2%
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 20
- Advanced biosensing and bioanalysis techniques 13
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 6
- Drug Solubulity and Delivery Systems 5
- Biological Psychiatry top 5%
-
- Nanoplatforms for cancer theranostics 27
- Graphene and Nanomaterials Applications 6
-
- Alzheimer's disease research and treatments 7
- Journals
- Biomaterials (10 papers)Journal of Controlled Release (7 papers)Biomaterials Science (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yang Ding
100 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Biomaterials 796
- Cancer Research 873
- Molecular Biology 3.4k
- Pharmaceutical Science 263
- Biological Psychiatry 104
Countries citing papers authored by Yang Ding
This map shows the geographic impact of Yang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ding more than expected).
Fields of papers citing papers by Yang Ding
This network shows the impact of papers produced by Yang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ding. The network helps show where Yang Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 20 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 30 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 14 | |
| 10 | 2021 | 155 | |
| 11 | 2021 | 6 | |
| 12 | 2019 | 11 | |
| 13 | 2018 | 48 | |
| 14 | 2018 | 34 | |
| 15 | 2018 | 38 | |
| 16 | 2015 | 50 | |
| 17 | 2014 | 84 | |
| 18 | Study of different extracts from water caltrop shells on inhibiting lung cancer cell line A549 | 2012 | 1 |
| 19 | 2012 | 111 | |
| 20 | 2010 | 7 |
About Yang Ding
Yang Ding is a scholar working on Biomaterials, Pharmaceutical Science and Biological Psychiatry, having authored 108 papers that have together received 6.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (29 papers), Nanoplatforms for cancer theranostics (27 papers), RNA Interference and Gene Delivery (20 papers), Advanced biosensing and bioanalysis techniques (13 papers), Alzheimer's disease research and treatments (7 papers), Graphene and Nanomaterials Applications (6 papers), Advanced Drug Delivery Systems (6 papers) and Drug Solubulity and Delivery Systems (5 papers). The work is most often cited by research in Biomaterials (796 citations), Cancer Research (873 citations) and Molecular Biology (3.4k citations). Yang Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Chen Xie, Jiaju Huang, Shan Dong, Chuan‐Yun Li, Xizeng Mao, Liping Wei, Jianmin Wu, Ge Gao, Lei Kong and Jianping Zhou. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Biomaterials Science, Advanced Science and Nano Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.